Literature DB >> 10992528

Peritoneal culture alters Streptococcus pneumoniae protein profiles and virulence properties.

C J Orihuela1, R Janssen, C W Robb, D A Watson, D W Niesel.   

Abstract

We have examined the properties of Streptococcus pneumoniae cultured in the murine peritoneal cavity and compared its virulence-associated characteristics to those of cultures grown in vitro. Analysis of mRNA levels for specific virulence factors demonstrated a 2.8-fold increase in ply expression and a 2.2-fold increase in capA3 expression during murine peritoneal culture (MPC). Two-dimensional gels and immunoblots using convalescent-phase patient sera and murine sera revealed distinct differences in protein production in vivo (MPC). MPC-grown pneumococci adhered to A549 epithelial cell lines at levels 10-fold greater than those cultured in vitro.

Entities:  

Keywords:  NASA Discipline Environmental Health; Non-NASA Center

Mesh:

Substances:

Year:  2000        PMID: 10992528      PMCID: PMC101580          DOI: 10.1128/IAI.68.10.6082-6086.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniae.

Authors:  J C Paton
Journal:  Trends Microbiol       Date:  1996-03       Impact factor: 17.079

Review 2.  Common themes in microbial pathogenicity revisited.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

3.  Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization.

Authors:  J N Weiser; R Austrian; P K Sreenivasan; H R Masure
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

4.  Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae.

Authors:  C Rosenow; P Ryan; J N Weiser; S Johnson; P Fontan; A Ortqvist; H R Masure
Journal:  Mol Microbiol       Date:  1997-09       Impact factor: 3.501

5.  Uptake of Streptococcus pneumoniae by respiratory epithelial cells.

Authors:  U M Talbot; A W Paton; J C Paton
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

6.  Bacterial infection as assessed by in vivo gene expression.

Authors:  D M Heithoff; C P Conner; P C Hanna; S M Julio; U Hentschel; M J Mahan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

7.  Antibiotic-based selection for bacterial genes that are specifically induced during infection of a host.

Authors:  M J Mahan; J W Tobias; J M Slauch; P C Hanna; R J Collier; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

8.  Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae strain in the chinchilla otitis media model.

Authors:  K Sato; M K Quartey; C L Liebeler; C T Le; G S Giebink
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus.

Authors:  J R Canvin; A P Marvin; M Sivakumaran; J C Paton; G J Boulnois; P W Andrew; T J Mitchell
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

10.  Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes.

Authors:  S Houldsworth; P W Andrew; T J Mitchell
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

View more
  9 in total

1.  Changes in availability of oxygen accentuate differences in capsular polysaccharide expression by phenotypic variants and clinical isolates of Streptococcus pneumoniae.

Authors:  J N Weiser; D Bae; H Epino; S B Gordon; M Kapoor; L A Zenewicz; M Shchepetov
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  In vivo studies of Clostridium perfringens in mouse gas gangrene model.

Authors:  Nabonita Sengupta; Syed Imteyaz Alam
Journal:  Curr Microbiol       Date:  2010-11-19       Impact factor: 2.188

3.  Streptococcus pneumoniae PstS production is phosphate responsive and enhanced during growth in the murine peritoneal cavity.

Authors:  C J Orihuela; J Mills; C W Robb; C J Wilson; D A Watson; D W Niesel
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

4.  Anatomical Site-Specific Carbohydrate Availability Impacts Streptococcus pneumoniae Virulence and Fitness during Colonization and Disease.

Authors:  Hansol Im; Katherine L Kruckow; Adonis D'Mello; Feroze Ganaie; Eriel Martinez; Jennifer N Luck; Kyle H Cichos; Ashleigh N Riegler; Xiuhong Song; Elie Ghanem; Jamil S Saad; Moon H Nahm; Hervé Tettelin; Carlos J Orihuela
Journal:  Infect Immun       Date:  2021-11-08       Impact factor: 3.609

5.  Microarray analysis of pneumococcal gene expression during invasive disease.

Authors:  Carlos J Orihuela; Jana N Radin; Jack E Sublett; Geli Gao; Deepak Kaushal; Elaine I Tuomanen
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  Peritoneal challenge modulates expression of pneumococcal surface protein C during bacteremia in mice.

Authors:  Lisa R Quin; Quincy C Moore; Justin A Thornton; Larry S McDaniel
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441

7.  Pneumococcal virulence gene expression and host cytokine profiles during pathogenesis of invasive disease.

Authors:  Layla K Mahdi; Abiodun D Ogunniyi; Kim S LeMessurier; James C Paton
Journal:  Infect Immun       Date:  2007-11-26       Impact factor: 3.441

8.  Development of a model of focal pneumococcal pneumonia in young rats.

Authors:  Richard Malley; Anne M Stack; Robert N Husson; Claudette M Thompson; Gary R Fleisher; Richard A Saladino
Journal:  J Immune Based Ther Vaccines       Date:  2004-01-23

9.  Transcriptional and metabolic effects of glucose on Streptococcus pneumoniae sugar metabolism.

Authors:  Laura Paixão; José Caldas; Tomas G Kloosterman; Oscar P Kuipers; Susana Vinga; Ana R Neves
Journal:  Front Microbiol       Date:  2015-10-07       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.